Publications by authors named "Terri Sebree"

Claim this Profile
L
Long-term safety and tolerability of transdermal cannabidiol gel in children and adolescents with Fragile X syndrome (ZYN2-CL-017): an interim analysis of an ongoing open-label extension study.
Elizabeth Berry-Kravis, Randi Hagerman, Jonathan Cohen, Dejan Budimirovic, Caroline B Buchanan, Terri Sebree

J Neurodev Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.
Joseph M Palumbo, Brian F Thomas, Dejan Budimirovic, Steven Siegel, Flora Tassone, Terri Sebree

J Neurodev Disord· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, Craig Erickson, Helen Heussler, Terri Sebree

J Neurodev Disord· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial.
Terence J O'Brien, Samuel F Berkovic, Jacqueline A French, John A Messenheimer, Terri B Sebree

JAMA Netw Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial.
Ingrid E Scheffer, Joe Hulihan, John Messenheimer, Shayma Ali, Ngaire Keenan, Terri Sebree

JAMA Netw Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.
Helen Heussler, Jonathan Cohen, Natalie Silove, Nancy Tich, Marcel O Bonn-Miller, Terri Sebree

J Neurodev Disord· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
Jerzy Zieba, Duncan Sinclair, Terri Sebree, Marcel Bonn-Miller, Donna Gutterman

Pharmacol Biochem Behav· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.
Marcel O Bonn-Miller, Stan L Banks, Terri Sebree

Cannabis Cannabinoid Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.
John Merrick, Brian Lane, Terri Sebree, Tony Yaksh, Carol O'Neill

Cannabis Cannabinoid Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of transdermal sumatriptan is too low for general use - a response.
Jerome Goldstein, Timothy Smith, Neil Pugach, James Griesser, Terri Sebree

Headache· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
Mark Pierce, Carol O'Neill, Ezra Felker, Terri Sebree

Headache· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
Jerome Goldstein, Timothy R Smith, Neil Pugach, Jim Griesser, Terri Sebree

Headache· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zelrix: a novel transdermal formulation of sumatriptan.
Mark Pierce, Thomas Marbury, Carol O'Neill, Steven Siegel, Wei Du, Terri Sebree

Headache· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
Steven J Siegel, Carol O'Neill, Louise M Dubé, Peter Kaldeway, Russell Morris, Terri Sebree

Pharm Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis